47 results
8-K
EX-99.1
PRAX
Praxis Precision Medicines Inc
9 Nov 22
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4:03pm
September 30, 2022, partially offset by $4.3 million in net proceeds from at-the-market offerings of shares of the Company's common stock. The Company’s cash … of $2.7 million was primarily attributable to $6.5 million in decreased clinical-related spend for the Company's Psychiatry franchise, partially offset
8-K
EX-99.1
PRAX
Praxis Precision Medicines Inc
9 Aug 23
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2023 Financial Results
8:27am
public offering and $24.1 million in net proceeds from at-the-market offerings of shares of Praxis’ common stock, partially offset by cash used … -related expenses, partially offset by $5.7 million in increased expenses related to the Solidus™ platform, which includes a $6.9 million one-time milestone
8-K
EX-99.1
PRAX
Praxis Precision Medicines Inc
13 May 24
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2024 Financial Results
8:18am
, partially offset by $2.4 million in decreased expenses related to the Company’s Solidus™ platform.
General and administrative expenses were $15.3 million … and administrative expenses of approximately $2.0 million was primarily due to an increase in personnel-related costs, partially offset by a decrease in consulting
DEFA14A
wfcljytoldilv5918c2
29 Apr 21
Additional proxy soliciting materials
4:08pm
8-K
EX-99.1
4mkkzhyevte5
7 Nov 23
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2023 Financial Results
7:35am
8-K
EX-99.1
u3312 ns9dwja9uj
28 Feb 22
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
6:06am
8-K
EX-99.1
16umim6 pk7
3 Nov 21
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2021 Financial Results
7:04am
8-K
EX-99.1
yhcf2ikj wt8z5
16 Aug 21
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2021 Financial Results
8:04am
8-K
EX-10.1
ez8hngr9pv3wzb
2 Jun 21
Entry into a Material Definitive Agreement
4:25pm
8-K
EX-99.1
ufl4y3ta7zeqxztmv
5 Mar 24
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
7:13am
8-K
EX-99.1
do1fr7exmm0a 5p
17 Mar 21
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
7:17am